+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 61 Pages
  • June 2023
  • GlobalData
  • Teijin Limited
  • ID: 4415744
Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teijin Ltd (Teijin) is a technology-driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products and pharmaceutical products. The company offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, and other diseases. It also offers homecare services such as home oxygen therapy devices, sonic accelerated fracture healing systems and sleep-disordered breathing-related devices, among others. Teijin operates facilities in Europe, America, Asia and Japan. The company sells its products in Asia, the Americas and Europe. Teijin is headquartered in Tokyo, Japan.

Teijin Ltd Key Recent Developments

May 11, 2023: Teijin Announces Consolidated Financial Statements Summary (For the year ended March 31, 2023)
Feb 21, 2023: Teijin and Axcelead sign deal for drug discovery research JV
Feb 08, 2023: Teijin Announces Consolidated Financial Statements Summary For the nine months ended December 31, 2022
Sep 27, 2022: Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Teijin Ltd - Key Facts
  • Teijin Ltd - Key Employees
  • Teijin Ltd - Key Employee Biographies
  • Teijin Ltd - Major Products and Services
  • Teijin Ltd - History
  • Teijin Ltd - Company Statement
  • Teijin Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Teijin Ltd - Business Description
  • Business Segment: Fibers and Products Converting
  • Overview
  • Performance
  • Business Segment: Healthcare
  • Overview
  • Performance
  • Business Segment: IT
  • Overview
  • Performance
  • Business Segment: Materials
  • Overview
  • Performance
  • Business Segment: Others
  • Overview
  • Performance
  • Geographical Segment: Americas (ex-U.S.)
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe, Others
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: PRC
  • Performance
  • Geographical Segment: U.S.
  • Performance
  • R&D Overview
  • Teijin Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Teijin Ltd - Strengths
  • Teijin Ltd - Weaknesses
  • Teijin Ltd - Opportunities
  • Teijin Ltd - Threats
  • Teijin Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Teijin Ltd, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Teijin Ltd, Petrochemicals, Deals By Type, 2017 to YTD 2023
  • Teijin Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 11, 2023: Teijin Announces Consolidated Financial Statements Summary (For the year ended March 31, 2023)
  • Feb 21, 2023: Teijin and Axcelead sign deal for drug discovery research JV
  • Feb 08, 2023: Teijin Announces Consolidated Financial Statements Summary For the nine months ended December 31, 2022
  • Sep 27, 2022: Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform
  • Aug 31, 2022: Teijin Holdings Usa President Jane Thomas Appointed Again to U.s. Commerce Department Investment Advisory Council
  • Mar 31, 2022: Teijin Consolidated Financial Statements Summary
  • Feb 16, 2022: Teijin Expands Thermoplastic Prepreg Lineup
  • Feb 04, 2022: Corporate Teijin has made the following personnel changes effective as of June 22, 2022
  • Feb 04, 2022: Corporate Teijin has made the following personnel changes effective as of April 1, 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Teijin Ltd, Key Facts
  • Teijin Ltd, Key Employees
  • Teijin Ltd, Key Employee Biographies
  • Teijin Ltd, Major Products and Services
  • Teijin Ltd, History
  • Teijin Ltd, Other Locations
  • Teijin Ltd, Subsidiaries
  • Teijin Ltd, Joint Venture
  • Teijin Ltd, Key Competitors
  • Teijin Ltd, Ratios based on current share price
  • Teijin Ltd, Annual Ratios
  • Teijin Ltd, Interim Ratios
  • Teijin Ltd, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Teijin Ltd, Petrochemicals, Deals By Type, 2017 to YTD 2023
  • Teijin Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Teijin Ltd, Performance Chart (2019 - 2023)
  • Teijin Ltd, Ratio Charts
  • Teijin Ltd, Petrochemicals, Deals By Year, 2017 to YTD 2023
  • Teijin Ltd, Petrochemicals, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sumitomo Chemical Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Dow Chemical Co
  • Celanese Corp
  • Mitsubishi Chemical Corp
  • Kaneka Corp
  • Nippon Chemical Industrial Co Ltd